Research, an opportunity not to be missed – A blog by Dr Shiva Pandey
In his blog Dr Shiva Pandey shares why he is encouraging other junior doctors to consider research as an opportunity not to be missed.
Read moreNews & Events category:
WTWA
Wythenshawe, Trafford, Withington and Altrincham
Trial to assess Acute Kidney Injury risk prediction technology starts at MFT
A pioneering clinical trial of new technology to predict the risk of patients developing Acute Kidney Injury (AKI) has begun at MFT.
Read more
MFT Cancer Professor features in Julia Bradbury breast cancer documentary
A leading MFT cancer professor MFT features in a documentary following TV presenter Julia Bradbury’s personal breast cancer journey.
Read more
NHS develops world-first bedside genetic test to prevent babies going deaf
A world-first genetic test, developed in Manchester, that could save the hearing of hundreds of babies each year has been successfully piloted in the NHS.
Read more
Trials carried out at MFT show drug eases symptoms of chronic cough
The results of the world’s first Phase 3 trials, of a new drug Gefapixant, show that it can ease the often distressing symptoms of chronic cough, with minimal side effects.
Read more
Manchester research contributes to NICE recommendation of new peanut allergy treatment for children
Children in the UK will be able to receive Palforzia – a life-changing oral treatment for peanut allergies – as NHS standard of care following approval for use by NICE.
Read more
First participants take part in study aboard Greater Manchester’s Research Van
The first participants have been involved in a study onboard Greater Manchester’s new state-of-the-art Research Van.
Read more
Manchester researchers and patients contribute to study showing people with long COVID after hospitalisation face limited recovery after one year
People who were hospitalised with COVID-19 and continued to experience symptoms at five months show limited further recovery one year after hospital discharge, according to latest research.
Read more
